Kidney cancer
17,141 new cases in France in 2023 1
What is it?
This is mainly renal cell carcinoma, which arises from cells in the kidney tubules. The main subtype is clear cell carcinoma (about 3 in 4 cases) 2.
How it develops
The tumor first grows in the kidney, then may cross its capsule, reach the renal vein and lymph nodes, and finally other organs (lungs, bones, liver) 2.
How long does it take to develop?
No average duration has been established. Small tumors monitored without treatment grow slowly, by around 2 to 4 mm per year; about 1 % develop metastases during monitoring 3.
Risk factors
- Tobacco
- Excess weight and obesity
- High blood pressure
- Advanced kidney failure or dialysis
- Family history and hereditary syndromes (von Hippel-Lindau…)
- Certain occupational exposures (trichloroethylene, cadmium)
What helps protect you: Stopping smoking, a stable weight, controlled blood pressure 4.
Signs that should prompt a visit to your doctor
In the early stages
- Often no symptoms
- Often found by chance during an ultrasound
As it progresses
- Blood in the urine
- Pain in the side
- A lump in the lower back
At an advanced stage
- A cough or shortness of breath
- Bone pain
- Weight loss, unexplained fever
These signs do not mean you have cancer: they may have other causes. Unsure? Talk to your doctor.
⁵Small tumors often cause no signs: more than half are found by chance during an ultrasound or CT scan. See a doctor for blood in the urine, persistent pain on one side of the lower back or unexplained fatigue 2.
Detected early or at a later stage
In the United States, 66 % of kidney cancers are found at the localized stage, often by chance; 17 % at the regional stage, 15 % distant 6.
5-year survival by stage
In France, 5-year net survival: 70 % 7.
Approximate correspondence with the clinical classification (TNM/FIGO); this varies depending on the tumour's characteristics.
Screening in France
No, there is no organized kidney cancer screening in France.
Monitoring for people at risk
People with a hereditary syndrome (particularly von Hippel-Lindau) receive imaging surveillance at a specialist center 2.

Prevonco is currently available in France only.
An aid to the early detection of 16 cancers
No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.
Pre-register for free →Frequently asked questions
Do I need a prescription?
No. With Prevonco, you do not need a prescription: after ordering online, a unique code gives you access to the test at one of our partner laboratories. In France, some laboratory tests can be carried out at your request, without a prescription.
No prescription, but still a doctor: they remain central to the process. Your result is sent to the doctor you selected from our panel, who will explain it during a 30-minute video consultation, included whatever the result.
Are you receiving care for cancer? Speak directly to your oncologist: they can prescribe this test without going through Prevonco.
For any questions about your situation, or if you have symptoms, your doctor remains your first point of contact.
What if my level is high?
A high level tends to be a strong signal. It is not a conclusion: its cause needs to be investigated with a doctor.⁸
Your result is sent to the doctor you selected from our panel. They will explain it during the 30-minute video consultation included in the price. Further investigations prescribed by a doctor can help identify the cause.⁸
What if the level is intermediate? It may not be related to cancer (smoking, an inflammatory condition, etc.). Other blood tests may be suggested; if they are normal, a repeat check is planned at 12 months. You will never be left to face your result alone.⁸
What if my level is low?
That is reassuring, but no test is perfect: a low level does not rule everything out.⁸
If you have no symptoms, no specific follow-up is recommended after a low result. The risk of a false negative varies by cancer type.⁸
Your doctor, who is trained in functional medicine and specialises in prevention, will help you explore any concerns or symptoms during the 30-minute video consultation.⁸
Keep up with your usual screening: respond to invitations for organised screening programmes, and see your doctor if a symptom appears.⁸
How long will it take to get my results?
The laboratory analysis takes 30 days. Your full results are presented by a doctor trained in functional medicine during a 30-minute consultation included in your package.
You choose the date and time slot that suit you for this appointment.
Prevonco is currently available in France only.
An aid to the early detection of 16 cancers
No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.
Pre-register for free →General information for educational purposes: it does not replace your doctor's advice. An aid to early detection: it does not replace organised screening, imaging tests or your doctor's advice.
Sources
- 1.INCa, Panorama des cancers en France, 2026
- 2.American Family Physician, Renal Cell Carcinoma: Diagnosis and Management, 2019
- 3.Urology Times, small renal masses grow slowly
- 4.American Cancer Society, Kidney Cancer Risk Factors
- 5.INCa (cancer.fr, 02/06/2022); Fondation ARC, 2026
- 6.NCI SEER, Cancer Stat Facts – Kidney and Renal Pelvis Cancer (2016-2022)
- 7.Santé publique France, survie 1989-2018 – rein
- 8.biodena.care